Your browser doesn't support javascript.
loading
Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling.
Wang, Jianlin; Luo, Judong; Sun, Zhiqiang; Sun, Fei; Kong, Ze; Yu, Jingping.
Affiliation
  • Wang J; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University.
  • Luo J; Center for Medical Physics, Nanjing Medical University, Changzhou, Jiangsu Province, China.
  • Sun Z; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University.
  • Sun F; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University.
  • Kong Z; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University.
  • Yu J; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University.
Medicine (Baltimore) ; 99(37): e22194, 2020 Sep 11.
Article in En | MEDLINE | ID: mdl-32925794
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Multifunctional Enzymes / Aminohydrolases / Methylenetetrahydrofolate Dehydrogenase (NADP) Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Multifunctional Enzymes / Aminohydrolases / Methylenetetrahydrofolate Dehydrogenase (NADP) Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2020 Type: Article